Actively Recruiting
Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
Led by Tri-Service General Hospital · Updated on 2026-01-08
40
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
Sponsors
T
Tri-Service General Hospital
Lead Sponsor
B
Balay Biotechnology Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized trial will test whether Antrodia cinnamomea supplement improves quality of life in lung cancer patients receiving platinum-based chemotherapy. Participants at Tri-Service General Hospital will be randomized to receive either Antrodia cinnamomea capsules or placebo for 3 months, with follow-up to 6 months (24 weeks). Primary outcomes include nausea/vomiting scores, sleep quality, quality of life, and cancer symptoms.
CONDITIONS
Official Title
Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with lung cancer confirmed by pathology and imaging
- Age greater than 18 years
- Receiving platinum-based chemotherapy
- Life expectancy of six months or longer
You will not qualify if you...
- Unable to comply with timely supplement intake
- Abnormal liver or kidney function within 14 days before enrollment
- Fever of 38.5°C or higher for 7 consecutive days or chronic diarrhea for 15 consecutive days within 30 days before enrollment
- Currently receiving hormone therapy
- Severe heart disease or arrhythmia as judged by the attending physician
- Major neuropathy
- Active acute infections
- Known allergies to the investigational product or its components
- Currently taking supplements containing Antrodia camphorata extract
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tri-Service General Hospital
Taipei, Taiwan, 114
Actively Recruiting
Research Team
C
Chen-Liang Tsai
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here